Article info
Commentary
What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus’
- Correspondence to Dr Maud Lemoine, Department of Surgery and Cancer, Hepatology Section, St Mary’s Hospital, London W2 1NY, UK; m.lemoine{at}imperial.ac.uk
Citation
What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus’
Publication history
- Received May 4, 2018
- Revised May 10, 2018
- Accepted May 10, 2018
- First published June 29, 2018.
Online issue publication
October 08, 2018
Article Versions
- Previous version (29 June 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.